The ophthalmic devices market is expected to see steady growth in response to escalating ophthalmic disease rates, lifestyle choices, and environmental influences. The US population over age 65 will s
IN VITRO DIAGNOSTICS 23andMe Inc. 23andMe brings in $50mm through its Series D venture round 23andMe Inc. (personalized genetics) has raised $50mm through its Series D venture round. New inves